Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The GATS protein-like 2 pseudogene (GATSL2 pseudogene; ENSG00000275121) is annotated as a pseudogene in the human genome, meaning it is a non-functional segment resembling a protein-coding gene but generally lacks the ability to produce a functional protein. It is not considered a therapeutic target, nor is it classified under typical target families like receptors, enzymes, or channels. No biological functions, disease associations, or drug interactions have been established for this pseudogene. The name GATS protein-like 2 pseudogene and related aliases (e.g., GATS-like protein 1, GATS-like protein 2, GATSL1) refer to non-functional or orphan gene entries and should not be confused with genuine drug targets or functional proteins. If you are seeking information on a functional or druggable target with a similar name (for example, GATS-like, GATSL, or CASTOR1/Cytosolic arginine sensor for mTORC1 subunit 1, which are bona fide proteins), please specify, as this entry does not correspond to a protein with established therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GATS protein-like 2 pseudogene (GATSL2 pseudogene).